Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconaz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Abastabar, Mahdi, Haghani, Iman, Shokohi, Tahereh, Hedayati, Mohammad Taghi, Aghili, Seyed Reza, Jedi, Ali, Dadashi, Sulmaz, Shabanzadeh, Shafigheh, Hosseini, Tahereh, Aslani, Narges, Meis, Jacques F., Badali, Hamid
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256807/
https://ncbi.nlm.nih.gov/pubmed/30224524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01632-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados